Sign In
Buy NHS
$6.20
-0.0300 (-0.482%)
At Close: Jul 13, 2026
NHS: Stay Away From This 17% Yielder As Rates Rise (Rating Downgrade)
12:19pm, Wednesday, 01'st Jul 2026
Neuberger High Yield Strategies Fund is downgraded to a sell due to persistent NAV erosion and unsustainable distributions. NHS trades at a 6.6% discount to NAV and offers a 17.4% yield, but earnings
NEUBERGER HIGH YIELD STRATEGIES FUND ANNOUNCES MONTHLY DISTRIBUTION
04:30pm, Tuesday, 30'th Jun 2026
NEW YORK, June 30, 2026 /PRNewswire/ -- Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The d
Northumbria Healthcare NHS Foundation Trust has modernised and standardised its UPS infrastructure across multiple hospital and community sites through a £1m project with Schneider Electric Working w
OneAdvanced Launches the UK's First Private Sovereign Healthcare LLM Trained on NHS Primary Care Data with NVIDIA
03:30am, Tuesday, 09'th Jun 2026
BIRMINGHAM, England--(BUSINESS WIRE)--OneAdvanced, one of the UK's largest providers of sector-focused SaaS software, today announced the successful completion of a pilot programme with NVIDIA, to dev
NHS England to roll out Microsoft 365 Copilot to 505,000 clinicians and support staff in largest implementation of its kind in the healthcare sector New agreement follows initial trial across 30,000 N
ComEd to Provide $2.5 Million in Bill Relief to Help Small Businesses Offset Rising PJM Supply Costs
02:00pm, Thursday, 04'th Jun 2026
Today, ComEd, together with its community partners, announced $2.5 million in new bill assistance that will soon be available to help eligible business custome
GRAIL Reports Full Results From NHS-Galleri Trial Demonstrating Substantial Reduction in Stage IV Cancer Diagnoses at 2026 ASCO Annual Meeting
NEUBERGER HIGH YIELD STRATEGIES FUND ANNOUNCES MONTHLY DISTRIBUTION
05:48pm, Friday, 29'th May 2026
/PRNewswire/ -- Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of
NEUBERGER HIGH YIELD STRATEGIES FUND ANNOUNCES MONTHLY DISTRIBUTION
05:05pm, Friday, 29'th May 2026
NEW YORK, May 29, 2026 /PRNewswire/ -- Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The di
NEUBERGER HIGH YIELD STRATEGIES FUND ANNOUNCES MONTHLY DISTRIBUTION
04:30pm, Thursday, 30'th Apr 2026
NEW YORK, April 30, 2026 /PRNewswire/ -- Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The
NEUBERGER HIGH YIELD STRATEGIES FUND ANNOUNCES FINAL RESULTS OF RIGHTS OFFERING
06:00pm, Monday, 20'th Apr 2026
NEW YORK, April 20, 2026 /PRNewswire/ -- Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced today the final results of its transferable rights offering (the "Off
NHS: Too Expensive Given The Unsustainable Distribution And Bond Market Troubles
05:50am, Saturday, 18'th Apr 2026
The Neuberger High Yield Strategies Fund offers a headline 16.66% yield, the highest among closed-end junk bond peers. NHS is not covering its distribution with investment income, as net asset value h
NEUBERGER HIGH YIELD STRATEGIES FUND ANNOUNCES PRELIMINARY RESULTS OF RIGHTS OFFERING
08:30am, Thursday, 16'th Apr 2026
NEW YORK, April 16, 2026 /PRNewswire/ -- Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced today the preliminary results of its transferable rights offering (th
Novo Nordisk stock surges 4%: can NHS boost offset pricing pressure?
07:29am, Wednesday, 01'st Apr 2026
Novo Nordisk stock surged on Wednesday after a major policy win, which is seen as a turning point for the drugmaker. England's cost-effectiveness watchdog has backed broader use of Wegovy to cut the r
Eli Lilly seeks higher NHS drug prices, rebate overhaul to restart UK investment, FT reports
12:49am, Monday, 30'th Mar 2026
Eli Lilly wants the UK to regularly raise NHS drug prices and phase out a multi-billion-pound rebate scheme if it is to resume investment, its international businesses president Patrik Jonsson t
